AbbVie Inc. [ABBV] stock is down -1.00 while the S&P 500 has fallen -0.61% on Wednesday, 10/14/20. While at the time of this article, ABBV ATR is sitting at 1.70, with the beta value at 0.68. This stock’s volatility for the past week remained at 1.57%, while it was 1.78% for the past 30-day period. ABBV has fallen -$0.86 from the previous closing price of $86.07 on volume of 2.04 million shares.
On 9, October 2020, Allergan Aesthetics To Present Data From 4 Abstracts At The 2020 American Society For Dermatologic Surgery Virtual Meeting. According to news published on Yahoo Finance, Today, Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced today that it will present 4 abstracts at the annual American Society for Dermatologic Surgery (ASDS) virtual meeting from October 9-11, 2020.
Analyst Birdseye View:
The most recent analyst activity for AbbVie Inc. [NYSE:ABBV] stock was on June 23, 2020, when it was Upgrade with an Overweight rating from Atlantic Equities, which also raised its 12-month price target on the stock to $115. Before that, on September 29, 2020, Berenberg Recapitulated a Hold rating and elevated its amount target to $98. On June 09, 2020, Wolfe Research Upgrade an Outperform rating. On June 02, 2020, Argus Upgrade a Buy rating and increased its price target to $115. On May 18, 2020, BofA/Merrill Resumed a Neutral rating and increased its price target to $95. On May 12, 2020, JP Morgan Upgrade an Overweight rating and boosted its amount on this stock to $105. On May 11, 2020, Morgan Stanley Resumed an Overweight rating and boosted its target amount on this stock to $95. On April 20, 2020, RBC Capital Mkts Upgrade an Outperform rating and amplified its amount target to $93.
In the past 52 weeks of trading, this stock has oscillated between a low of $62.55 and a peak of $101.28. Right now, according to Wall Street analyst the average 12-month amount target is $109.29. At the most recent market close, shares of AbbVie Inc. [NYSE:ABBV] were valued at $85.21. According to the average price forecast, investors can expect a potential return of 0.8%.
AbbVie Inc. [NYSE:ABBV] most recently reported quarterly sales of 10.43 billion, which represented growth of 26.30%. This publicly-traded organization’s revenue is $1,108,867 per employee, while its income is $261,400 per employee. This company’s Gross Margin is currently 73.30%, its Operating Margin is 30.20%, its Pretax Margin is +25.33, and its Net Margin is +23.57.
The Principal structure of this organization shows its whole liability to whole principal at 113.87 and the whole liability to whole assets at 75.28. It shows enduring liability to the whole principal at 107.32 and enduring liability to assets at 0.71 while looking for an extended time period.
Readers are usually of view to make a close observation to the indicators that support and make resistance before moving to any particular stock. As of now, the company’s stock is sitting at 85.61 points at 1st support level, the second support level is making up to 85.15. But as of 1st resistance point, this stock is sitting at 86.82 and at 87.57 for 2nd resistance point.
AbbVie Inc. [ABBV] reported its earnings at $2.34 per share in the fiscal quarter closing of 6/29/2020. The Analysts for Wall Street were expecting to report its earnings at $2.19/share signifying the difference of 0.15 and 6.80% surprise value. Comparing the previous quarter ending of 3/30/2020, the stated earnings were $2.42 calling estimates for $2.25/share with the difference of 0.17 depicting the surprise of 7.60%.
Important Ratio’s To Watch
Meanwhile, turning our focus to liquidity, the Current Ratio for AbbVie Inc. [NYSE:ABBV] is 0.90. Likewise, the Quick ratio is also the same, showing Cash ratio at 2.56. Now if looking for a valuation of this stock’s amount to sales ratio it’s 3.95 and showing 18.93 of P/E (TTM) ratio.
The most recent insider trade was by ALBAN CARLOS, Vice Chairman, and it was the sale of 53325.0 shares on Jul 07. Stewart Jeffrey Ryan, the SVP, US Commercial Operations, completed a sale of 23024.0 shares on May 12. On May 05, RICHMOND TIMOTHY J., EVP, Chief HR Officer, completed a sale of 19445.0 shares.